Skip to content

Exploring Innovations in Pharma Research

The Gubra Blog

Welcome to the Gubra Blog, where we explore the latest advancements in preclinical and clinical research. Dive into our insights on drug development, metabolic diseases, and innovative treatment strategies. Stay informed and ahead in the pharmaceutical and biotechnology industries.

Filters
Search
Category
Sort result
CRO servicesLiverMASHMASH-HCC

FDA approves semaglutide (Wegovy®) for MASH: What does this mean for drug development and preclinical innovation?

As the drug development landscape evolves, the need for reliable and translational preclinical MASH models has never been greater.

6 min read

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 ­2650

Back To Top